Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France

View ORCID ProfileSamira Fafi-Kremer, View ORCID ProfileTimothée Bruel, View ORCID ProfileYoann Madec, Rebecca Grant, Laura Tondeur, View ORCID ProfileLudivine Grzelak, Isabelle Staropoli, François Anna, Philippe Souque, View ORCID ProfileCatherine Schmidt-Mutter, View ORCID ProfileNicolas Collongues, Alexandre Bolle, Aurélie Velay, Nicolas Lefebvre, Marie Mielcarek, View ORCID ProfileNicolas Meyer, David Rey, View ORCID ProfilePierre Charneau, View ORCID ProfileBruno Hoen, View ORCID ProfileJérôme De Seze, View ORCID ProfileOlivier Schwartz, Arnaud Fontanet
doi: https://doi.org/10.1101/2020.05.19.20101832
Samira Fafi-Kremer
1CHU de Strasbourg, Laboratoire de virologie, F-67091 Strasbourg, France
2Université de Strasbourg, INSERM, IRM UMR_S 1109, Strasbourg, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Samira Fafi-Kremer
  • For correspondence: samira.fafi-kremer@chru-strasbourg.fr timothee.bruel@pasteur.fr
Timothée Bruel
3Virus & Immunity Unit, Department of Virology, Institut Pasteur, Paris, France; CNRS UMR 3569, Paris, France; Vaccine Research Institute, Creteil, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Timothée Bruel
  • For correspondence: samira.fafi-kremer@chru-strasbourg.fr timothee.bruel@pasteur.fr
Yoann Madec
4Institut Pasteur, Emerging Diseases Epidemiology Unit, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yoann Madec
Rebecca Grant
4Institut Pasteur, Emerging Diseases Epidemiology Unit, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura Tondeur
4Institut Pasteur, Emerging Diseases Epidemiology Unit, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ludivine Grzelak
3Virus & Immunity Unit, Department of Virology, Institut Pasteur, Paris, France; CNRS UMR 3569, Paris, France; Vaccine Research Institute, Creteil, France
5Université de Paris, Sorbonne Paris Cité, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ludivine Grzelak
Isabelle Staropoli
3Virus & Immunity Unit, Department of Virology, Institut Pasteur, Paris, France; CNRS UMR 3569, Paris, France; Vaccine Research Institute, Creteil, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
François Anna
6Pasteur-TheraVectys joined unit
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philippe Souque
7Molecular Virology & Vaccinology Unit, Department of Virology, Institut Pasteur, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Catherine Schmidt-Mutter
8Centre d’investigation Clinique INSERM 1434, CHU Strasbourg, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Catherine Schmidt-Mutter
Nicolas Collongues
8Centre d’investigation Clinique INSERM 1434, CHU Strasbourg, France
14CHU de Strasbourg, Service de Neurologie, F-67091 Strasbourg, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nicolas Collongues
Alexandre Bolle
8Centre d’investigation Clinique INSERM 1434, CHU Strasbourg, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aurélie Velay
1CHU de Strasbourg, Laboratoire de virologie, F-67091 Strasbourg, France
2Université de Strasbourg, INSERM, IRM UMR_S 1109, Strasbourg, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicolas Lefebvre
9CHU de Strasbourg, Service des infectieuses et tropicales, F-67091 Strasbourg, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marie Mielcarek
10CHU de Strasbourg, Service de santé Publique, GMRC, F-67091 Strasbourg, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicolas Meyer
10CHU de Strasbourg, Service de santé Publique, GMRC, F-67091 Strasbourg, France
11Université de Strasbourg, CNRS, iCUBE UMR 7357, Strasbourg, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nicolas Meyer
David Rey
12CHU de Strasbourg, Pôle SMO, le Trait d’Union, F-67091 Strasbourg, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pierre Charneau
6Pasteur-TheraVectys joined unit
7Molecular Virology & Vaccinology Unit, Department of Virology, Institut Pasteur, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Pierre Charneau
Bruno Hoen
13Direction de la recherche médicale, Institut Pasteur, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Bruno Hoen
Jérôme De Seze
8Centre d’investigation Clinique INSERM 1434, CHU Strasbourg, France
14CHU de Strasbourg, Service de Neurologie, F-67091 Strasbourg, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jérôme De Seze
Olivier Schwartz
3Virus & Immunity Unit, Department of Virology, Institut Pasteur, Paris, France; CNRS UMR 3569, Paris, France; Vaccine Research Institute, Creteil, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Olivier Schwartz
Arnaud Fontanet
4Institut Pasteur, Emerging Diseases Epidemiology Unit, Paris, France
15Conservatoire National des Arts et Métiers, PACRI Unit, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background The serologic response of individuals with mild forms of SARS-CoV-2 infection is poorly characterized.

Methods Hospital staff who had recovered from mild forms of PCR-confirmed SARS-CoV-2 infection were tested for anti-SARS-CoV-2 antibodies using two assays: a rapid immunodiagnostic test (99.4% specificity) and the S-Flow assay (∼99% specificity).The neutralizing activity of the sera was tested with a pseudovirus-based assay.

Results Of 162 hospital staff who participated in the investigation, 160 reported SARS-CoV-2 infection that had not required hospital admission and were included in these analyses. The median time from symptom onset to blood sample collection was 24 days (IQR: 21–28, range 13–39). The rapid immunodiagnostic test detected antibodies in 153 (95.6%) of the samples and the S-Flow assay in 159 (99.4%), failing to detect antibodies in one sample collected 18 days after symptom onset (the rapid test did not detect antibodies in that patient). Neutralizing antibodies (NAbs) were detected in 79%, 92% and 98% of samples collected 13–20, 21–27 and 28–41 days after symptom onset, respectively (P=0.02).

Conclusion Antibodies against SARS-CoV-2 were detected in virtually all hospital staff sampled from 13 days after the onset of COVID-19 symptoms. This finding supports the use of serologic testing for the diagnosis of individuals who have recovered from SARS-CoV-2 infection. The neutralizing activity of the antibodies increased overtime. Future studies will help assess the persistence of the humoral response and its associated neutralization capacity in recovered patients.

Competing Interest Statement

SFK, TB, YM, RG, LT, LG, IS, FA, PS, CSM, NC, AB, AV, NL, MM, NM, DR, BH, JDS, OS and AF have no competing interest to declare. PC is the founder and CSO of TheraVectys.

Clinical Trial

NCT04325646

Funding Statement

OS lab is funded by Institut Pasteur, ANRS, Sidaction, the Vaccine Research Institute (ANR- 10-LABX-77), Labex IBEID (ANR-10-LABX-62-IBEID), “TIMTAMDEN” ANR-14-CE14-0029, “CHIKV-Viro- Immuno” ANR-14-CE14-0015-01 and the Gilead HIV cure program. LG is supported by the French Ministry of Higher Education, Research and Innovation. AF lab is funded by Labex IBEID (ANR-10-LABX-62-IBEID) and the INCEPTION project (PIA/ANR-16-CONV-0005). SFK lab receives funding from Strasbourg University Hospitals (COVID-HUS ; CE-2020-34)

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was registered with ClinicalTrials.gov (NCT04325646) and received ethical approval by the Comite de Protection des Personnes Ile de France III. Informed consent was obtained from all participants.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵* Co-first authors

  • ↵** Co-last authors

Data Availability

All data generated or analysed during this study are included in this published article (and its supplementary information files).

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted May 22, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France
Samira Fafi-Kremer, Timothée Bruel, Yoann Madec, Rebecca Grant, Laura Tondeur, Ludivine Grzelak, Isabelle Staropoli, François Anna, Philippe Souque, Catherine Schmidt-Mutter, Nicolas Collongues, Alexandre Bolle, Aurélie Velay, Nicolas Lefebvre, Marie Mielcarek, Nicolas Meyer, David Rey, Pierre Charneau, Bruno Hoen, Jérôme De Seze, Olivier Schwartz, Arnaud Fontanet
medRxiv 2020.05.19.20101832; doi: https://doi.org/10.1101/2020.05.19.20101832
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France
Samira Fafi-Kremer, Timothée Bruel, Yoann Madec, Rebecca Grant, Laura Tondeur, Ludivine Grzelak, Isabelle Staropoli, François Anna, Philippe Souque, Catherine Schmidt-Mutter, Nicolas Collongues, Alexandre Bolle, Aurélie Velay, Nicolas Lefebvre, Marie Mielcarek, Nicolas Meyer, David Rey, Pierre Charneau, Bruno Hoen, Jérôme De Seze, Olivier Schwartz, Arnaud Fontanet
medRxiv 2020.05.19.20101832; doi: https://doi.org/10.1101/2020.05.19.20101832

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (280)
  • Allergy and Immunology (579)
  • Anesthesia (139)
  • Cardiovascular Medicine (1947)
  • Dentistry and Oral Medicine (252)
  • Dermatology (184)
  • Emergency Medicine (333)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (699)
  • Epidemiology (11102)
  • Forensic Medicine (8)
  • Gastroenterology (624)
  • Genetic and Genomic Medicine (3168)
  • Geriatric Medicine (308)
  • Health Economics (561)
  • Health Informatics (2042)
  • Health Policy (863)
  • Health Systems and Quality Improvement (782)
  • Hematology (310)
  • HIV/AIDS (682)
  • Infectious Diseases (except HIV/AIDS) (12720)
  • Intensive Care and Critical Care Medicine (707)
  • Medical Education (317)
  • Medical Ethics (92)
  • Nephrology (334)
  • Neurology (2986)
  • Nursing (164)
  • Nutrition (463)
  • Obstetrics and Gynecology (589)
  • Occupational and Environmental Health (614)
  • Oncology (1552)
  • Ophthalmology (477)
  • Orthopedics (185)
  • Otolaryngology (266)
  • Pain Medicine (202)
  • Palliative Medicine (57)
  • Pathology (403)
  • Pediatrics (912)
  • Pharmacology and Therapeutics (381)
  • Primary Care Research (355)
  • Psychiatry and Clinical Psychology (2785)
  • Public and Global Health (5591)
  • Radiology and Imaging (1094)
  • Rehabilitation Medicine and Physical Therapy (635)
  • Respiratory Medicine (760)
  • Rheumatology (338)
  • Sexual and Reproductive Health (311)
  • Sports Medicine (289)
  • Surgery (343)
  • Toxicology (48)
  • Transplantation (159)
  • Urology (132)